One in four myeloma specialists do not tell their patients about licensed drugs not yet approved by the UK NICE

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.562, 2008-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NICE recommends four drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 644, 2012-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Study shows continued variation in use of NICE-approved drugs

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 621, 2011-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Public misconceptions about FDA-approved drugs

Reactions Weekly, Vol. 1, Iss. 1372, 2011-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Nearly 200 X-Ray Crystal Structures of Transthyretin: What Do They Tell Us About This Protein and the Design of Drugs for TTR Amyloidoses?

Current Medicinal Chemistry, Vol. 19, Iss. 15, 2012-04 ,pp. : 2324-2342

Bentham Science Publishers

Access to resources Recommend Favorite

The UK NICE guidelines on the use of drugs to treat Alzheimer's disease `are sensible'

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 323, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite